Brandywine Global Investment Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$11.68 - $20.72 $474,943 - $842,537	-40,663 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$18.52 - $22.55 $48,152 - $58,630	-2,600 Reduced 6.01%	40,663 $796,000
Q1 2021 May 13, 2021	SELL	$20.25 - $39.49 $6,156 - $12,004	-304 Reduced 0.7%	43,263 $920,000
Q4 2020 Feb 10, 2021	SELL	$21.17 - $32.61 $55,253 - $85,112	-2,610 Reduced 5.65%	43,567 $1.3 Million
Q3 2020 Nov 12, 2020	BUY	$18.13 - $30.61 $89,670 - $151,397	4,946 Added 12.0%	46,177 $1 Million
Q2 2020 Aug 14, 2020	BUY	$14.41 - $25.35 $5,230 - $9,202	363 Added 0.89%	41,231 $920,000
Q1 2020 May 15, 2020	BUY	$13.16 - $22.9 $537,822 - $935,877	40,868 New	40,868 $623,000

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

Primecap Management CO Pasadena, CA

7.22M
Shares

$448 Million
0.28% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$418 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$397 Million
3.59% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$377 Million
4.44% of portfolio
Goldman Sachs Group Inc New York, NY

3.88M
Shares

$241 Million
0.03% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.46B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account